Examining the association between the “My Pharmacist” model and the service quality of community pharmacies

Goto, Keiko; Sato, Tsugumichi; Shikamura, Yoshiaki; Nomura, Kaori; Negishi, Kenichi; Hanawa, Takehisa

doi:10.1016/j.sapharm.2019.10.012

Cited by 3 publications

(1 citation statement)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In April 2016, the kakaritsuke-yakuzaishi system (henceforth, the family pharmacist system) was implemented in Japan by adjusting the kakaritsuke-yakuzaishi-shidouryo (henceforth, the family pharmacist consultation fees) to assist community pharmacies. The family pharmacist system aims to facilitate centralized and consistent pharmaceutical care [ 5 , 6 ] and enable the delivery of more effective and comprehensive pharmaceutical services by developing patient–pharmacist contracts. To claim fees within this system, family pharmacists must provide various services, such as 24-h availability for consultations, tracking dispensing information from other pharmacies, and gathering feedback from physicians.…”

Section: Introductionmentioning

confidence: 99%

Identification of individuals benefiting from the kakaritsuke-yakuzaishi (family pharmacist) system in Japan: a retrospective cohort study using an employment-based health insurance claims database

Iketani

Konomura

2022

BMC Health Serv Res

View full text Add to dashboard Cite

Background The kakaritsuke-yakuzaishi system (henceforth, the family pharmacist system) which provides more health services than those by general pharmaceutical practice, was implemented in Japan in April 2016. To distribute medical resources and medical care expenditures appropriately, identifying the possible major beneficiaries of this system is essential. By analyzing administrative claims data through this retrospective cohort study, we identified modifiers of the potential benefits of the system. Further, we integrated the identified modifiers into a scoring system that indicates the possible benefitting subpopulations. Methods We obtained data about individuals under 75 years old routinely using community pharmacies in Japan from the JMDC database. We classified the individuals as users or non-users. We used claims related to “choufukutouyaku-sougosayoutou-boushi-kasan (additional therapeutic duplication and drug interaction [TDDI] prevention fees)” filed between April 2018 and March 2020, which indicate that individuals’ prescriptions were modified to adjust leftover drugs or to avoid TDDI as indicators of potential benefit. We estimated adjusted absolute risk differences and 95% confidence intervals for product terms using multiple generalized linear regression models. We included the factors whose 95% confidence interval lower limits did not reach 0 in the multiple logistic regression models for developing a scoring system. Results The eligible cohort included 162,340 individuals (1,214 users and 161,126 non-users). The leftover drugs adjustment significantly increased for individuals prescribed antidepressants. However, as only one modifier was identified, we did not develop a scoring system for the leftover drugs adjustment. For TDDI prevention, the following factors were included in the scoring system: being female, being prescribed ≥ 6 drug types, using ≥ 2 medical institutions, and being prescribed proton pump inhibitors, antibiotics, probiotics, or traditional Japanese herbal medicines. The developed scoring system for TDDI prevention scored “female” and “traditional Japanese herbal medicines prescription” factors higher than other factors. Conclusions Individuals who are female or prescribed traditional Japanese herbal medicines, or antidepressants may benefit significantly from the family pharmacist system.

show abstract

Section: Introductionmentioning

confidence: 99%

Identification of individuals benefiting from the kakaritsuke-yakuzaishi (family pharmacist) system in Japan: a retrospective cohort study using an employment-based health insurance claims database

Iketani

Konomura

2022

BMC Health Serv Res

View full text Add to dashboard Cite

show abstract

Developing a quality framework for community pharmacy: a systematic review of international literature

Hindi,

Campbell,

Jacobs

et al. 2024

BMJ Open

View full text Add to dashboard Cite

ObjectiveTo identify the defining features of the quality of community pharmacy (CP) services and synthesise these into an evidence-based quality framework.DesignSystematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.Data sourcesInternational research evidence (2005 onwards) identified from six electronic databases (Embase, PubMed, Scopus, CINAHL, Web of Science and PsycINFO) was reviewed systematically from October 2022 to January 2023. Search terms related to ‘community pharmacy’ and ‘quality’.Eligibility criteria for selecting studiesTitles and abstracts were screened against inclusion or exclusion criteria, followed by full-text screening by at least two authors. Qualitative, quantitative and mixed-method studies relevant to quality in CP were included.Data extraction and synthesisA narrative synthesis was undertaken. Following narrative synthesis, a patient and public involvement event was held to further refine the quality framework.ResultsFollowing the title and abstract screening of 11 493 papers, a total of 81 studies (qualitative and quantitative) were included. Of the 81 included studies, 43 investigated quality dimensions and/or factors influencing CP service quality; 21 studies assessed patient satisfaction with and/or preferences for CP, and 17 studies reported the development and assessment of quality indicators, standards and guidelines for CPs, which can help define quality.The quality framework emerging from the global literature consisted of six dimensions: person-centred care, access, environment, safety, competence and integration within local healthcare systems. Quality was defined as having timely and physical access to personalised care in a suitable environment that is safe and effective, with staff competent in the dispensing process and pharmacy professionals possessing clinical knowledge and diagnostic skills to assess and advise patients relative to pharmacists’ increasingly clinical roles.ConclusionThe emerging framework could be used to measure and improve the quality of CP services. Further research and feasibility testing are needed to validate the framework according to the local healthcare context.

show abstract

かかりつけ薬剤師制度が新型コロナウイルス感染症流行下の脂質異常症患者のアドヒアランスに及ぼす影響

Maeda,

Hasegawa,

Tsukioka

et al. 2023

YAKUGAKU ZASSHI

View full text Add to dashboard Cite

The pharmacy pharmacist s function as a family pharmacist is expected to improve adherence to medication in patients suffering from chronic diseases, including dyslipidemia. This is true even in infectious disease epidemics. In this study, using anonymously processed receipt data from 700 insurance pharmacies in our group, we evaluated medication adherence in patients taking statin drugs before, during the first and second years of coronavirus disease 2019 (COVID-19) epidemic in terms of medication persistence and medication possession, and compared the results between the family pharmacist group (FP group) and non-family pharmacist group (NoFP group). The odds ratios of good medication adherence (medication persistence and medication possession) rates for the FP group relative to the NoFP group were 1.446 [95% confidence interval (CI): 1.210-1.727] in the pre-epidemic period, 1.428 (1.192-1.710) in the first year of the epidemic, and 1. 270 (1.113-1.450) in the second year of the epidemic. The FP group was significantly higher in all time periods. Therefore, it is suggested that the family pharmacist function improves adherence to statins not only before but also during the COVID-19 epidemic.

show abstract

Examining the association between the “My Pharmacist” model and the service quality of community pharmacies

Cited by 3 publications

References 19 publications

Identification of individuals benefiting from the kakaritsuke-yakuzaishi (family pharmacist) system in Japan: a retrospective cohort study using an employment-based health insurance claims database

Identification of individuals benefiting from the kakaritsuke-yakuzaishi (family pharmacist) system in Japan: a retrospective cohort study using an employment-based health insurance claims database

Developing a quality framework for community pharmacy: a systematic review of international literature

かかりつけ薬剤師制度が新型コロナウイルス感染症流行下の脂質異常症患者のアドヒアランスに及ぼす影響

Contact Info

Product

Resources

About